Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed COO
|
|
Invivyd, Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 12/06/2022 |
8-K
| Appointed COO|
Docs:
|
"FORM 8-K",
"Employment Agreement, by and between Invivyd, Inc. and Jeremy Gowler",
"INVIVYD APPOINTS JEREMY GOWLER AS CHIEF OPERATING AND COMMERCIAL OFFICER, PROMOTES PETE SCHMIDT, M.D., TO CHIEF MEDICAL OFFICER WALTHAM, MASS; December 06, 2022 - Invivyd, Inc. , a clinical-stage biopharmaceutical company on a mission to protect humanity from serious viral respiratory diseases, today announced the appointment of Jeremy Gowler as chief operating and commercial officer, effective December 16, 2022, and the promotion of Pete Schmidt, M.D. to chief medical officer, effective immediately. In his new role Mr. Gowler will oversee operations and commercial activities for the company. Dr. Schmidt will be responsible for overseeing all medical, clinical development and regulatory activities at Invivyd. Dr. Ellie Hershberger, Invivyd's chief development officer, is departing from the..." |
|
|
|